| Literature DB >> 26377311 |
Karol Gliniewicz1,2, Mark Wildung3, Lisa H Orfe4, Gregory D Wiens5, Kenneth D Cain6, Kevin K Lahmers7,8, Kevin R Snekvik9,10, Douglas R Call11,12.
Abstract
BACKGROUND: Flavobacterium psychrophilum is the etiologic agent of bacterial coldwater disease in salmonids. Earlier research showed that a rifampicin-passaged strain of F. psychrophilum (CSF 259-93B.17) caused no disease in rainbow trout (Oncorhynchus mykiss, Walbaum) while inducing a protective immune response against challenge with the virulent CSF 259-93 strain. We hypothesized that rifampicin passage leads to an accumulation of genomic mutations that, by chance, reduce virulence. To assess the pattern of phenotypic and genotypic changes associated with passage, we examined proteomic, LPS and single-nucleotide polymorphism (SNP) differences for two F. psychrophilum strains (CSF 259-93 and THC 02-90) that were passaged with and without rifampicin selection.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26377311 PMCID: PMC4571129 DOI: 10.1186/s12866-015-0518-1
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Growth curves of F. psychrophilum CSF 259–93 and THC 02–90 parent and passaged strains. Independent triplicates of each strain were grown statically in TYES broth at 16 °C with optical density measurements at 450–580 nm preceded by brief shacking. Abbreviations used: CW - F. psychrophilum CSF 259–93 parent strain, CN and CR – CSF 259–93 passaged 17 times with no and with rifampicin, respectively; B17 – rifampicin attenuated F. psychrophilum CSF 259-93B.17 strain [13]; TW - THC 02–90 parent strain and TN and TR – THC 02–90 passaged for 17 times with and without rifampicin, respectively
Fig. 2Light micrographs showing representative colony edges after 3-day incubation at 16 °C on gliding motility agar. CW – wild-type CSF 259.93; CN – CSF 259–93 passaged without rifampicin; CR– CSF 259–93 passaged with rifampicin; B17 – attenuated CSF 259.93B.17; TW – wild-type THC 02–90; TN – THC 02–90 passaged without rifampicin; TR – THC 02–90 passaged with rifampicin; white bars indicate 200 μm scale
Fig. 32D PAGE analysis of whole-cell lysates from the F. psychrophilum strains. Proteins were stained with SyPro Ruby gel stain and molecular weight markers (kDa) are indicated on the left of each gel. Red ovals designate proteins reproducibly greater abundance as compared to the respective (CW or TW) parent strain. CW – wild-type CSF 259.93; CN – CSF 259–93 passaged without rifampicin; CR– CSF 259–93 passaged with rifampicin; B17 – attenuated CSF 259.93B.17; TW – wild-type THC 02–90; TN – THC 02–90 passaged without rifampicin; TR – THC 02–90 passaged with rifampicin
Summary of output from IonTorrent and 454 sequencing for seven F. psychrophilum strains
| Sample | Mb totala | Number of reads (in millions) | Mean read length (in bp) |
|---|---|---|---|
| CSF 259–93 wild-type (CW)b | 603 | 2.46 | 245 |
| CSF 259–93 passaged w/o Rif (CN)b | 346 | 1.37 | 254 |
| CSF 259–93 passaged with Rif (CR)b | 772 | 2.97 | 261 |
| THC 02–90 wild-type (TW)b | 620 | 2.38 | 260 |
| THC 02–90 passaged w/o Rif (TN)b | 676 | 2.78 | 244 |
| THC 02–90 passaged with Rif (TR)b | 666 | 2.78 | 240 |
| CSF 259–93 wild-type (CW)c | 63.1 | 0.18 | N/A |
| CSF 259-93B.17 (B17)c | 167 | 0.45 | N/A |
aMb total = total number of mega bases of DNA sequences
bResults from Ion Torrent sequencing, 316 chip
cResults from 454 sequencing
Single nucleotide polymorphisms (SNPs) in F. psychrophilum strains used in our experiments
| NONSYNONYMOUS SNPs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| SYNONYMOUS SNPs | CW | CN | CR | TW | TN | TR | ERGO | B17 | |
| CW | n.a. | 5 | 8 | 85 | 113 | 123 | 19 | 14 | |
| CN | 32 | n.a. | 3 | 105 | 141 | 117 | 25 | N.D. | |
| CR | 34 | 33 | n.a. | 113 | 158 | 108 | 28 | N.D. | |
| TW | 161 | 170 | 174 | n.a. | 126 | 174 | 100 | N.D. | |
| TN | 233 | 142 | 146 | 177 | n.a. | 48 | 102 | N.D. | |
| TR | 278 | 287 | 291 | 257 | 180 | n.a. | 132 | N.D. | |
| ERGO | 37 | 75 | 78 | 206 | 208 | 238 | n.a. | 33 | |
| B17 | 45 | N.D. | N.D. | N.D. | N.D. | N.D. | 50 | n.a. | |
CW wild type CSF 259–93, CN CSF 259–93 passaged without Rif, CR CSF 259–93 passaged with Rif, TW wild type THC 02–90, TN THC 02–90 passaged without Rif, THC 02–90 passaged with Rif, B17 – CSF 259-93B.17
N.D. not determined due to these genomes being sequenced at different times and by different methods
n.a. = not applicable
Analysis of single nucleotide polymorphisms (SNPs) from F. psychrophilum CSF 259–93 used in our laboratory
| Reference positiona | Allele frequency (in %)b | SNPc | Coveraged | Annotatione | Amino acid changee | Gene/Proteinf |
|---|---|---|---|---|---|---|
| 721449 | 100 | C > A | 72 | FPSM_00632 | Gly111Trp | Hypothetical protein |
| 742016 | 100 | A > G | 70 | FPSM_00646 | Ser615Gly | Type II restriction-modification system methylation subunit |
| 899151 | 100 | C > A | 84 | FPSM_00800 | Phe215Leu | RmuC family protein |
| 899152 | 100 | G > A | 92 | FPSM_00800 | Gly216Glu | |
| 921140 | 96.7 | C > A | 90 | FPSM_00823 | Pro254Thr | Hypothetical protein (similar to FP1973-GldK gliding motility protein) |
| 1257208 | 100 | C > G | 98 | FPSM_01126 | Trp148Ser | Putative membrane spanning protein |
| 1333946 | 97.7 | A > T | 43 | FPSM_01204 | Phe507Ile | Glucose/galactose transporter |
| 1334321 | 98.7 | A > C | 78 | FPSM_01204 | Tyr382Asp | |
| 1387849 | 95.1 | T > G | 61 | FPSM_01258 | Leu133Arg | Phage related protein |
| 1387851 | 100 | T > G | 99 | FPSM_01258 | Tyr134Asn | |
| 1537329 | 98.7 | C > G | 75 | FPSM_01388 | Arg547Thr | TonB-dependent outer membrane receptor |
| 1630279 | 92 | A > C | 25 | FPSM_01473 | Thr160Pro | Transposase |
| 1664395 | 100 | C > G | 81 | FPSM_01493 | Val213Leu | Cation efflux system plasma membrane protein (similar to FP0880 – probable multidrug resistance protein precursor AcrB/D/F family) |
| 1664410 | 99 | G > C | 96 | FPSM_01493 | Pro208Ala | |
| 1970401 | 97.4 | T > C | 116 | FPSM_01788 | Ser383Gly | Von Willebrand factor type A domain protein (FP0550 – |
| 1970443 | 100 | C > T | 122 | FPSM_01788 | Asp369Asn | |
| 2066236 | 100 | C > A | 76 | FPSM_01870 | His300Asn | Hypothetical protein |
| 2514049 | 98.5 | C > G | 130 | FPSM_02290 | Leu293Val | 3-oxoacyl-(acyl carrier-protein) synthase III (FP1374 |
| 2737510 | 100 | C > G | 119 | FPSM_02485 | Leu163Phe | tRNA pseudouridine synthase B (FP2357 |
aReference position (in bp) for reference sequence (listed under annotation field) are based on CSF 259–93 sequence from ERGO-Integrated genomics
bAllele frequency refers to the proportion of sequences showing a given single-nucleotide polymorphism (SNP) at the started reference position
cShows the SNP change represents the change from nucleotide X to Y (X > Y) at the reference position
dCoverage refers to the total number of sequencing reads that align to each base within the sample DNA
ePredicted amino acid change for the identified SNP
fAnnotation shows the name and putative function for the identified gene
Single nucleotide polymorphisms (SNPs) from F. psychrophilum CSF 259-93B.17 strain
| Reference positiona | Allele frequency (in %)b | SNPc | Coveraged | Annotatione | Amino acid changee | Gene/Proteinf |
|---|---|---|---|---|---|---|
| 43576 | 100 | A > T | 5 | FPSM_00026 | Met1Leu | Multimodular transpeptidase-transglycosylase PBP 1A |
| 155877 | 100 | A > T | 43 | FPSM_00129 | Leu71Phe | Putative exported protein |
| 283611 | 80 | A > T | 10 | FPSM_00250 | Asn522Ile | Amino acid permease |
| 325469 | 100 | T > A | 4 | FPSM_00287 | Met1Leu | Thioredoxin |
| 488182 | 100 | A > C | 4 | FPSM_00425 | Gln466Pro | DNA primase |
| 514297 | 86.4 | C > T | 162 | FPSM_00445 | Ala11Thr | Malonyl-CoA-[acyl-carrier-protein] transacylase |
| 548737 | 100 | A > T | 5 | FPSM_00479 | Met1Leu | Ribosome recycling factor (RRF) |
| 846079 | 100 | T > A | 4 | FPSM_00743 | Phe98Tyr | Putative membrane spanning protein |
| 856484 | 85.7 | T > A | 7 | FPSM_00754 | Met13Leu | Hypothetical protein |
| 1334056 | 100 | A > C | 39 | FPSM_01204 | Phe470Cys | Glucose/galactose transporter |
| 1480580 | 80 | A > T | 5 | FPSM_01337 | Asn41Ile | Hypothetical protein |
| 1498680 | 100 | T > A | 4 | FPSM_01353 | Asn123Ile | Phosphoribosyl-ATP cyclohydrolase |
| 1522077 | 80 | T > A | 5 | FPSM_01375 | Met1Leu | Protein translation elongation factor P (EF-P) |
| 1537329 | 100 | C > G | 51 | FPSM_01388 | Arg547Thr | TonB-dependent outer membrane receptor |
aReference position (in bp) for reference sequence (listed under annotation field) are based on CSF 259–93 sequence from ERGO-Integrated genomics
bAllele frequency refers to the proportion of sequences showing a given single-nucleotide polymorphism (SNP) at the started reference position
cShows the SNP change represents the change from nucleotide X to Y (X > Y) at the reference position
dCoverage refers to the total number of sequencing reads that align to each base within the sample DNA
ePredicted amino acid change for the identified SNP
fAnnotation shows the name and putative function for the identified gene. Annotation is presented from the CSF 259–93 sequence from ERGO-Integrated genomics
Single nucleotide polymorphisms (SNPs) from F. psychrophilum CSF 259–93 strain passaged with no rifampicin (CN)
| Reference positiona | Allele frequency (in %)b | SNPc | Coveraged | Annotatione | Amino acid changee | Gene/Proteinf |
|---|---|---|---|---|---|---|
| 575838 | 100 | C > G | 71 | FPSM_00502 | Val638Leu | Ribonucleoside-diphosphate reductase large chain ( |
| 824811 | 94 | A > G | 50 | FPSM_00723 | Ile62Thr | GTP-binding protein YihA |
| 2606362 | 100 | G > T | 25 | FPSM_02361 | Trp4Leu | Putative membrane spanning protein |
| 2606399 | 95 | A > T | 20 | FPSM_02361 | Leu16Phe | |
| 2718910 | 100 | T > C | 83 | FPSM_02464 | Tyr418Cys | Di-tripeptide transporter |
aReference position (in bp) for reference sequence (listed under annotation field) are based on CSF 259–93 sequence from ERGO-Integrated genomics
bAllele frequency refers to the proportion of sequences showing a given single-nucleotide polymorphism (SNP) at the started reference position
cShows the SNP change represents the change from nucleotide X to Y (X > Y) at the reference position
dCoverage refers to the total number of sequencing reads that align to each base within the sample DNA
ePredicted amino acid change for the identified SNP
fAnnotation shows the name and putative function for the identified gene. Annotation is presented from the CSF 259–93 sequence from ERGO-Integrated genomics
Single nucleotide polymorphisms (SNPs) from F. psychrophilum CSF 259–93 strain passaged with rifampicin (CR)
| Reference positiona | Allele frequency (in %)b | SNPc | Coveraged | Annotatione | Amino acid changee | Gene/Proteinf |
|---|---|---|---|---|---|---|
| 575838 | 100 | C > G | 71 | FPSM_00502 | Val638Leu | Ribonucleoside-diphosphate reductase large chain ( |
| 824811 | 94 | A > G | 50 | FPSM_00723 | Ile62Thr | GTP-binding protein YihA |
| 1327825 | 100 | G > A | 138 | FPSM_01200 | Asp275Val | Hypothetical protein |
| 2111614 | 81.9 | C > A | 144 | FPSM_01917 | Thr365Lys | Phytoene desaturase ( |
| 2319546 | 98.8 | G > A | 167 | FPSM_02089 | Ser492Phe | DNA-directed RNA polymerase beta chain RpoB |
| 2606236 | 100 | G > T | 73 | FPSM_02361 | Trp4Leu | Putative membrane spanning protein |
| 2606399 | 100 | A > T | 65 | FPSM_02361 | Leu16Phe | |
| 2788973 | 97.1 | T > A | 105 | FPSM_02533 | Ile35Phe | Transcriptional regulator, TetR family |
aReference position (in bp) for reference sequence (listed under annotation field) are based on CSF 259–93 sequence from ERGO-Integrated genomics
bAllele frequency refers to the proportion of sequences showing a given single-nucleotide polymorphism (SNP) at the started reference position
cShows the SNP change represents the change from nucleotide X to Y (X > Y) at the reference position
dCoverage refers to the total number of sequencing reads that align to each base within the sample DNA
ePredicted amino acid change for the identified SNP
fAnnotation shows the name and putative function for the identified gene. Annotation is presented from the CSF 259–93 sequence from ERGO-Integrated genomics
Fig. 4Percent survival curves of rainbow trout (Oncorhynchus mykiss, Walbaum) fry challenged with different F. psychrophilum strains. a Challenges with different CSF 259–93 strains with (panel b). showing comparisons between different THC 02–90 strains. Statistically significant values (P < 0.005) are indicated by asterisks. CW – wild-type CSF 259.93; CN – CSF 259–93 passaged without rifampicin; CR– CSF 259–93 passaged with rifampicin; B17 – attenuated CSF 259.93B.17; TW – wild-type THC 02–90; TN – THC 02–90 passaged without rifampicin; TR – THC 02–90 passaged with rifampicin